Research areas include: Dual GLP-1 and GIP receptor pharmacology research [1] Body weight and visceral fat reduction models [1] Glucose-driven insulin release and beta cell studies Appetite and satiety pathway research Insulin resistance and type 2 diabetes models Cardiovascular and lipid profile research Studies that separate GLP-1 from GIP signalling How It Works Tirzepatide works by turning on the GLP-1 and GIP receptors at the same time
Combination Care May Help Some patients benefit from both approaches: surgery for durable weight loss and medication when additional appetite control is needed
Int J Pept Res Ther2026 Mar 10;32(2):38
- , [ ] ." Do you currently wear a CGM without a medical indication
Lower Blood Pressure: Some GLP-1 receptor agonists, like semaglutide and liraglutide, have also been shown to reduce blood pressure, offering an added benefit for individuals managing both high blood pressure and diabetes
Baseado em evidncias cientficas, o GHK-Cu um peptdeo biomimtico que participa ativamente dos processos naturais de reparo tecidual, reorganizao da matriz extracelular e modulao inflamatria, sendo amplamente utilizado em protocolos estticos quando corretamente formulado e aplicado
